Pharmacological inhibition of protein S-palmitoylation suppresses osteoclastogenesis and ameliorates ovariectomy-induced bone loss

Pharmacological inhibition of protein S-palmitoylation suppresses osteoclastogenesis and ameliorates ovariectomy-induced bone loss

Background: Excessive osteoclast formation disrupts bone homeostasis, thereby significantly contributing to pathological bone loss associated with a variety of diseases. Protein S-palmitoylation is a reversible post-translational lipid modification catalyzed by ZDHHC family of palmitoyl acyltransfer...

Full description

Bibliographic Details
Main Authors:	Linghui Ma, Liwei Zhang, Zirui Liao, Chunmei Xiu, Xi Luo, Na Luo, Lei Zhang, Guangxu He, Jianquan Chen
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Series:	Journal of Orthopaedic Translation
Subjects:	Protein S-palmitoylation 2-bromopalmitic acid Osteoclastogenesis Osteoporosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214031X23000451

Similar Items

Pu-erh Tea Extract Ameliorates Ovariectomy-Induced Osteoporosis in Rats and Suppresses Osteoclastogenesis In Vitro
by: Titi Liu, et al.
Published: (2017-05-01)

Aromatic Bis[aminomethylidenebis(phosphonic)] Acids Prevent Ovariectomy-Induced Bone Loss and Suppress Osteoclastogenesis in Mice
by: Anna Nasulewicz-Goldeman, et al.
Published: (2021-09-01)

Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
by: Dahu Qi, et al.
Published: (2021-01-01)

Parkin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss
by: Weiduo Hou, et al.
Published: (2022-10-01)

Pan-histone deacetylase inhibitor vorinostat suppresses osteoclastic bone resorption through modulation of RANKL-evoked signaling and ameliorates ovariectomy-induced bone loss
by: Xiaole Peng, et al.
Published: (2024-03-01)

Berbamine inhibits RANKL- and M-CSF-mediated osteoclastogenesis and alleviates ovariectomy-induced bone loss
by: Guobin Qi, et al.
Published: (2022-11-01)

Treatment of Trypanosoma cruzi with 2-bromopalmitate alters morphology, endocytosis, differentiation and infectivity
by: Cassiano Martin Batista, et al.
Published: (2018-08-01)

Water Extract of <i>Agastache rugosa</i> Prevents Ovariectomy-Induced Bone Loss by Inhibiting Osteoclastogenesis
by: Seon-A Jang, et al.
Published: (2020-08-01)

Aikeqing, a kidney- and spleen-tonifying compound Chinese medicine granule, prevented ovariectomy-induced bone loss in rats via the suppression of osteoclastogenesis
by: Zhi-Wen Liu, et al.
Published: (2023-10-01)

The Brown Algae <i>Ishige sinicola</i> Extract Ameliorates Ovariectomy-Induced Bone Loss in Rats and Suppresses Osteoclastogenesis through Downregulation of NFATc1/c-Fos
by: Mihyang Kim, et al.
Published: (2022-04-01)

Methyl 3,4-dihydroxybenzoate inhibits RANKL-induced osteoclastogenesis via Nrf2 signaling in vitro and suppresses LPS-induced osteolysis and ovariectomy-induced osteoporosis in vivo
by: Huang Zhaobo, et al.
Published: (2022-08-01)

Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss via Suppressing Osteoclastogenesis in Mice
by: Bao Huang, et al.
Published: (2019-08-01)

Anemoside B4 attenuates RANKL-induced osteoclastogenesis by upregulating Nrf2 and dampens ovariectomy-induced bone loss
by: Zhen Cao, et al.
Published: (2023-11-01)

STAT3-mediated osteogenesis and osteoclastogenesis in osteoporosis
by: Xiaoli Hou, et al.
Published: (2022-07-01)

Anti-Osteoporotic Effects of Commiphora Myrrha and Its Poly-Saccharide via Osteoclastogenesis Inhibition
by: Youn-Hwan Hwang, et al.
Published: (2021-05-01)

Acyltransferase zinc finger DHHC-type containing 2 aggravates gastric carcinoma growth by targeting Nrf2 signaling: A mechanism-based multicombination bionic nano-drug therapy
by: Luguang Liu, et al.
Published: (2024-04-01)

Palmitoylation of Metazoan Carotenoid Oxygenases
by: Sheetal Uppal, et al.
Published: (2020-04-01)

Isopsoralen suppresses receptor activator of nuclear factor kappa-β ligand-induced osteoclastogenesis by inhibiting the NF-κB signaling
by: Wanda Zhan, et al.
Published: (2023-01-01)

Orientin suppresses osteoclastogenesis and ameliorates ovariectomy‐induced osteoporosis via suppressing ROS production
by: Yan Zheng, et al.
Published: (2023-09-01)

Sulforaphane Inhibits Osteoclastogenesis via Suppression of the Autophagic Pathway
by: Tingting Luo, et al.
Published: (2021-01-01)

Dendrobium officinale Orchid Extract Prevents Ovariectomy-Induced Osteoporosis in Vivo and Inhibits RANKL-Induced Osteoclast Differentiation in Vitro
by: Qi Wang, et al.
Published: (2018-01-01)

Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis
by: Chang-hong Li, et al.
Published: (2021-12-01)

Receptor activator of nuclear factor-κB ligand-mediated osteoclastogenesis signaling pathway and related therapeutic natural compounds
by: Zechao Qu, et al.
Published: (2022-11-01)

Synergy effects of Asperosaponin VI and bioactive factor BMP-2 on osteogenesis and anti-osteoclastogenesis
by: Fangping Chen, et al.
Published: (2022-04-01)

(−)-Epicatechin 3-O-β-d-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways
by: Hung-Bo Hsiao, et al.
Published: (2017-05-01)

Aspirin prevents estrogen deficiency-induced bone loss by inhibiting osteoclastogenesis and promoting osteogenesis
by: Yongyun Chang, et al.
Published: (2023-03-01)

Corrigendum: Dendrobium officinale Orchid Extract Prevents Ovariectomy-Induced Osteoporosis In Vivo and Inhibits RANKL-Induced Osteoclast Differentiation In Vitro
by: Qi Wang, et al.
Published: (2020-04-01)

Corrigendum: Nitazoxanide, an antiprotozoal drug, reduces bone loss in ovariectomized mice by inhibition of RANKL-induced osteoclastogenesis
by: Chang-hong Li, et al.
Published: (2023-07-01)

Increased osteoclastogenesis contributes to bone loss in the Costello syndrome Hras G12V mouse model
by: Sayantan Nandi, et al.
Published: (2022-10-01)

Conditional knockout of PDK1 in osteoclasts suppressed osteoclastogenesis and ameliorated prostate cancer-induced osteolysis in murine model
by: Yanan Zhang, et al.
Published: (2023-10-01)

Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes
by: Konstantin Byrgazov, et al.
Published: (2021-12-01)

RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling
by: Jirong Wang, et al.
Published: (2023-04-01)

Corylifol A suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via attenuating ROS production and impairing mitochondrial function
by: HaiShan Li, et al.
Published: (2024-02-01)

Age-related decline in melatonin contributes to enhanced osteoclastogenesis via disruption of redox homeostasis
by: Di-Zheng Wu, et al.
Published: (2024-01-01)

Wnt7b Inhibits Osteoclastogenesis via AKT Activation and Glucose Metabolic Rewiring
by: Fanzi Wu, et al.
Published: (2021-11-01)

Palmitoylation regulates neuropilin-2 localization and function in cortical neurons and conveys specificity to semaphorin signaling via palmitoyl acyltransferases
by: Eleftheria Koropouli, et al.
Published: (2023-04-01)

Phospholipase C signaling activated by parathyroid hormone mediates the rapid osteoclastogenesis in the fracture healing of orchiectomized mice
by: Wei Li, et al.
Published: (2018-08-01)

BCI Suppresses RANKL-Mediated Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss
by: Chenhui Cai, et al.
Published: (2021-11-01)

Melatonin Attenuates RANKL-Induced Osteoclastogenesis via Inhibition of Atp6v0d2 and DC-STAMP through MAPK and NFATc1 Signaling Pathways
by: Seong-Sik Kim, et al.
Published: (2022-01-01)

Protein Palmitoylation in Leukocyte Signaling and Function
by: Xiaoyuan Yang, et al.
Published: (2020-10-01)